2014


To access this material please log in or register

Register Authorize
2014/№3

Noninvasive diagnostic methods for evaluation of risk in patientswith non-ST segment elevation acute coronary syndrome

Tsvetkov R. S., Mironkov A. B., Pryamikov A. D., Movsesyants M. Yu.

Keywords: diagnosis, non-ST elevation ACS, prognosis

DOI: 10.18087/rhj.2014.3.1917

The article presents data on possibilities for fast prognosis in ACS patients using simple methods for diagnosing ACS. Typical ECG symptoms, including ST segment shifts downward or upward from isoline, and their use for rapid assessment of the risk of death for a specific patient are described based on data of literature. Also, data on biochemical markers and their predictive roles are provided, and severity and risk scales developed for these patients are presented.
  1. de Winter RJ, Windhausen F, Cornel JH et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353 (11):1095–1104.
  2. Cheitlin MD, Armstrong WF, Aurigemma GP et al. ACC / AHA / ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (ACC / AHA / ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108 (9):1146–1162.
  3. Yeh RW, Sidney S, Chandra M et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362 (23):2155–2165.
  4. Fox KA, Eagle KA, Gore JM et al. The Global Registry of Acute Coronary Events, 1999 to 2009 – GRACE. Heart. 2010;96 (14):1095–1101.
  5. Cannon CP, Steinberg BA. Evidense-based cardiology. –3rd ed., 2011, 196–211.
  6. Cannon CP, McCabe CH, Stone PH et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. J Am Coll Cardiol. 1997;30 (1):133–140.
  7. Boersma E, Pieper KS, Steyerberg EW et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101 (22):2557–2567.
  8. Théroux P, Alexander JJr, Pharand C et al. Glycoprotein IIb / IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina / non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study. Circulation. 2000;102 (20):2466–2472.
  9. Roffi M, Chew DP, Mukherjee D et al. Platelet glycoprotein IIb / IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2001;104 (23):2767–2771.
  10. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351 (13):1285–1295.
  11. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351 (13):1296–1305.
  12. Weiner DE, Tighiouart H, Stark PC et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44 (2):198–206
  13. Granger CB, Goldberg RJ, Dabbous O et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163 (19):2345–2353.
  14. Antman EM, Cohen M, Bernink PJ et al. The TIMI risk score for unstable angina / non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284 (7):835–842.
  15. Fox KA, Dabbous OH, Goldberg RJ et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333 (7578):1091.
  16. Holmvang L, Clemmensen P, Lindahl B et al. Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol. 2003;41 (6):905–915.
  17. Kaul P, Fu Y, Chang WC et al. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb / IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001;38 (1):64–71.
  18. Gheorghiade M, Shivkumar K, Schultz L et al. Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. Am Heart J. 1993;126 (2):271–278.
  19. Kosuge M, Kimura K, Ishikawa T et al. Clinical implications of persistent ST segment depression after admission in patients with non-ST segment elevation acute coronary syndrome. Heart. 2005;91 (1):95–96.
  20. Hyde TA, French JK, Wong CK et al. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5‑mm ST-segment depression. Am J Cardiol. 1999;84 (4):379–385.
  21. de Zwaan C, Bar FW, Wellens HJ. Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impen­ding myocardial infarction. Am Heart J. 1982;103 (4 Pt 2):730–736.
  22. Rhinehardt J, Brady WJ, Perron AD, Mattu A. Electrocardiographic manifestations of Wellens' syndrome. Am J Emerg Med. 2002;20 (7):638–643.
  23. De Zwaan C, Bar FW, Janssen JH et al. Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery. Am Heart J. 1989;117 (3):657–665.
  24. Thygesen K, Mair J, Katus H et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31 (18):2197–2204.
  25. Hamm CW, Goldmann BU, Heeschen C et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997;337 (23):1648–1653.
  26. Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335 (18):1342–1349.
  27. Kontos MC, de Lemos JA, Ou FS et al. Troponin-positive, MBnegative patients with non-ST-elevation myocardial infarction: an undertreated but high-risk patient group: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry. Am Heart J. 2010;160 (5):819–825.
  28. James SK, Lindahl B, Siegbahn A et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO) – IV substudy. Circulation. 2003;108 (3):275–281.
  29. Steg PG, FitzGerald G, Fox KA. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. Am J Med. 2009;122 (2):107–108.
  30. Lindahl B, Toss H, Siegbahn A et al. Markers of myocardial dama­ge and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343 (16):1139–1147.
  31. Morrow DA, Rifai N, Antman EM et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 1998;31 (7):1460–1465.
  32. James SK, Lindahl B, Siegbahn A et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO) – IV substudy. Circulation. 2003;108 (3):275–281.
  33. de Lemos JA, Morrow DA, Bentley JH. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345 (14):1014–1021.
  34. Thygesen K, Mair J, Mueller C et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012;33 (16):2001–2006.
  35. Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105 (15):1760–1763.
  36. Antman EM, Cohen M, Bernink PJ et al. The TIMI risk score for unstable angina / non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284 (7):835–842.
  37. de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J. 2005;26 (9):865–872.
  38. Aragam KG, Tamhane UU, Kline-Rogers E et al. Does simpli­city compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One. 2009;4 (11):e7947.
  39. Eggers KM, Kempf T, Venge P et al. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. Am Heart J. 2010;160 (1):88–94.
Tsvetkov R. S., Mironkov A. B., Pryamikov A. D. et al. Noninvasive diagnostic methods for evaluation of risk in patientswith non-ST segment elevation acute coronary syndrome. Russian Heart Journal. 2014;77 (3):160–165

To access this material please log in or register

Register Authorize
Ru En